← SynDRA
NAQUOTINIB
SynDRA canonical compound SYN0038377 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | EGFR |
|---|
| Mechanism of action | EGFR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EGFR INHIBITOR
- Epidermal growth factor receptor erbB1 inhibitor
Drug classes
- Antineoplastic Agents
- Protein Kinase Inhibitors
Cross-references
Synonyms
- ASP-8273
- ASP8273
- naquotinibum
- RefChem:832062
- Naquotinib [USAN]
- e-2-carboxamide
- MFCD30496701
- Naquotinib(ASP8273)
- NAQUOTINIB [INN]
- Naquotinib (USAN/INN)
- ASP8273 (Naquotinib)
- Naquotinib; ASP-8273
- NAQUOTINIB [WHO-DD]
- UNII-47DD4548PB
- GTPL9248
- orb1296210
- SCHEMBL16196078
- SCHEMBL29355759
- BDBM170514
- EX-A2669
- NSC793322
- s8412
- AKOS032944996
- CCG-270060
- CS-5469
- NSC-793322
- NCGC00507838-02
- AC-35709
- AS-75247
- HY-19729
- NS00073604
- C91356
- D10958
- US9085540, 54
- F805206
- naquotinib (proposed INN)
- UNII-12T09LV21O
- ASP8273 mesilate
Look up NAQUOTINIB in the interactive SynDRA portal →